Marimed (MRMD) Amortizatization of Intangibles (2021 - 2026)
Marimed's (MRMD) quarterly Amortizatization of Intangibles came in at $115000.0 in Q1 2026, up 9.52% year-on-year from $105000.0 in Q1 2025, and down 4.17% on a QoQ basis from $120000.0 in Q4 2025.
Marimed (MRMD) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Marimed (MRMD) has 5 years of Amortizatization of Intangibles data on file, last reported at $115000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 9.52% year-over-year to $115000.0 in Q1 2026; TTM through Mar 2026 was $469000.0, a 24.73% increase from a year earlier, with the FY2025 full-year figure at $459000.0, up 28.21% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $115000.0, down from $120000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for MRMD reached as high as $1.3 million in Q2 2023 and fell as low as $87000.0 in Q1 2024.
- Historically, Amortizatization of Intangibles has averaged $291000.0 across 4 years, with a median of $117000.0 in 2025.
- Across the five-year window, Amortizatization of Intangibles tumbled 93.12% in 2024 and jumped 32.95% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $292000.0 in 2023, then tumbled by 68.15% to $93000.0 in 2024, then increased by 29.03% to $120000.0 in 2025, then decreased by 4.17% to $115000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $115000.0 in Q1 2026, $120000.0 in Q4 2025, and $117000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn | 115,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 115,000.00 |
| Mar 31, 2026 | 115,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Jun 30, 2025 | 117,000.00 |
| Jun 30, 2025 | 117,000.00 |
| Mar 31, 2025 | 105,000.00 |
| Mar 31, 2025 | 105,000.00 |
| Dec 31, 2024 | 93,000.00 |
| Dec 31, 2024 | 93,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Mar 31, 2024 | 87,000.00 |
| Mar 31, 2024 | 87,000.00 |
| Dec 31, 2023 | 292,000.00 |
| Dec 31, 2023 | 292,000.00 |